Pediatric Neurology
Volume 28, Issue 3 , Pages 194-198, March 2003

Prednisone therapy in pediatric epilepsy

  • D.Barry Sinclair, MD

      Affiliations

    • Comprehensive Epilepsy Program, University of Alberta, Edmonton, Alberta, Canada
    • Corresponding Author InformationCommunications should be addressed to: Dr. Sinclair; Director; Division of Pediatric Neurology; 2C3 Walter MacKenzie Health Sciences Centre; University of Alberta; Edmonton, AB, T6G 2B7, Canada

Received 11 April 2002; accepted 26 August 2002.

Abstract 

Steroids are often an effective treatment for the West’s syndrome. There have been few reports of steroid use in children with epilepsy outside the first year of life. I report my experience with prednisone for the treatment of older children with intractable epilepsy. Twenty-eight children (17 boys, 11 girls) aged 18 months to 10 years with intractable epilepsy were studied. Prednisone 1 mg/kg/day for 12 weeks (6 weeks daily and 6 weeks alternate therapy) was prescribed in addition to their regular antiepileptic medications. The parents kept seizure diaries, and the patients were regularly assessed for seizure frequency and side effects. The follow-up period was for 1 to 5 years. Thirteen patients (46%) became seizure free on prednisone and another 18 (40%) had a significant decrease in seizure frequency. Five patients (19%) had no change in seizure frequency. The best outcomes were seen in the absence group in which six out of seven patients became seizure free and in the Lennox-Gastaut syndrome group in which seven out of 10 became seizure free. Side effects were uncommon and included weight gain in five patients and aggression in four patients. Prednisone therapy is a safe and effective adjunctive treatment for epilepsy. It should be considered as an alternative treatment for older children with intractable generalized epilepsy who have failed conventional antiepileptic therapy.

Keywords:  pediatric epilepsy, corticosteroids

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0887-8994(02)00513-1

doi:10.1016/S0887-8994(02)00513-1

Pediatric Neurology
Volume 28, Issue 3 , Pages 194-198, March 2003